Medicare Rx Plans Have 15% Margin Of Error In Bids, Consultant Says
Executive Summary
Medicare prescription drug plans will be able to remain profitable in the early years of the drug benefit even if their costs exceed the assumptions underlying their bid by as much as 15%, according to an analysis performed by the Gorman Health Group
You may also be interested in...
Medicare Rx Bids Could Yield 30 Plan Choices Per Region – Schering Exec
Medicare beneficiaries could have 30 choices of Part D drug plans in certain regions based on estimates that CMS received 1,000 bids
Medicare Rx Bids Could Yield 30 Plan Choices Per Region – Schering Exec
Medicare beneficiaries could have 30 choices of Part D drug plans in certain regions based on estimates that CMS received 1,000 bids
Medicare Rx Could Include 150 Part D Plans, CMS Official Estimates
The Centers for Medicare & Medicaid Services anticipates that there will be up to 150 stand-alone Medicare Part D prescription drug plans in 2006, CMS Program Integrity Group Director Kimberly Brandt told the International Pharmaceutical Compliance Summit in Philadelphia April 1